
Trang T. Doan
Examiner (ID: 12998, Phone: (571)272-0740 , Office: P/2431 )
| Most Active Art Unit | 2431 |
| Art Unit(s) | 2431, 2131 |
| Total Applications | 761 |
| Issued Applications | 590 |
| Pending Applications | 58 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4676850
[patent_doc_number] => 20080214481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Methods of Treatment of Endobronchial Infections'
[patent_app_type] => utility
[patent_app_number] => 11/570584
[patent_app_country] => US
[patent_app_date] => 2005-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21273
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214481.pdf
[firstpage_image] =>[orig_patent_app_number] => 11570584
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/570584 | Methods of Treatment of Endobronchial Infections | Jun 19, 2005 | Abandoned |
Array
(
[id] => 4823134
[patent_doc_number] => 20080227746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Methods and Compositions for Treatment of Excess Nitric Oxide or Cyanide Toxicity'
[patent_app_type] => utility
[patent_app_number] => 11/630049
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25858
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227746.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630049
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630049 | Methods and compositions for treatment of excess nitric oxide or cyanide toxicity | Jun 16, 2005 | Issued |
Array
(
[id] => 23883
[patent_doc_number] => 07795227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Compounds and methods for treating seizure disorders'
[patent_app_type] => utility
[patent_app_number] => 11/155200
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 11144
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795227.pdf
[firstpage_image] =>[orig_patent_app_number] => 11155200
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/155200 | Compounds and methods for treating seizure disorders | Jun 16, 2005 | Issued |
Array
(
[id] => 518725
[patent_doc_number] => 07189704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => '6-11 bicyclic ketolide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/154260
[patent_app_country] => US
[patent_app_date] => 2005-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50967
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189704.pdf
[firstpage_image] =>[orig_patent_app_number] => 11154260
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/154260 | 6-11 bicyclic ketolide derivatives | Jun 15, 2005 | Issued |
Array
(
[id] => 453148
[patent_doc_number] => 07247617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-24
[patent_title] => 'Sixteen-member macrolide antiinfective agents'
[patent_app_type] => utility
[patent_app_number] => 11/154435
[patent_app_country] => US
[patent_app_date] => 2005-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14137
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/247/07247617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11154435
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/154435 | Sixteen-member macrolide antiinfective agents | Jun 14, 2005 | Issued |
Array
(
[id] => 5844372
[patent_doc_number] => 20060122144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Compounds resistant to metabolic deactivation and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/145550
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9182
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11145550
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/145550 | Compounds resistant to metabolic deactivation and methods of use | Jun 1, 2005 | Abandoned |
Array
(
[id] => 6952833
[patent_doc_number] => 20050227928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Glycoalkaloid compositions and various uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/143043
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7853
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227928.pdf
[firstpage_image] =>[orig_patent_app_number] => 11143043
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/143043 | Glycoalkaloid compositions and various uses thereof | Jun 1, 2005 | Abandoned |
Array
(
[id] => 6959255
[patent_doc_number] => 20050215496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Preparation and diabetic use of Gibberellins'
[patent_app_type] => utility
[patent_app_number] => 11/133207
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6907
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215496.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133207
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133207 | Preparation and diabetic use of Gibberellins | May 19, 2005 | Abandoned |
Array
(
[id] => 6967117
[patent_doc_number] => 20050234014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'O-sulphated bacterial polysaccharides and their use'
[patent_app_type] => utility
[patent_app_number] => 11/131636
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10389
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234014.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131636 | O-sulphated bacterial polysaccharides and their use | May 16, 2005 | Abandoned |
Array
(
[id] => 6959254
[patent_doc_number] => 20050215495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Macrolide antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/127701
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82092
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215495.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127701 | Macrolide antibiotics | May 11, 2005 | Abandoned |
Array
(
[id] => 7233063
[patent_doc_number] => 20050256062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Crystal forms of azithromycin'
[patent_app_type] => utility
[patent_app_number] => 11/123542
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 13842
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256062.pdf
[firstpage_image] =>[orig_patent_app_number] => 11123542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/123542 | Crystal forms of azithromycin | May 5, 2005 | Issued |
Array
(
[id] => 7070084
[patent_doc_number] => 20050245469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Crystal forms of azithromycin'
[patent_app_type] => utility
[patent_app_number] => 11/123770
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 13917
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245469.pdf
[firstpage_image] =>[orig_patent_app_number] => 11123770
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/123770 | Crystal forms of azithromycin | May 5, 2005 | Issued |
Array
(
[id] => 7233079
[patent_doc_number] => 20050256063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Crystal forms of azithromycin'
[patent_app_type] => utility
[patent_app_number] => 11/123703
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 13864
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11123703
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/123703 | Crystal forms of azithromycin | May 5, 2005 | Issued |
Array
(
[id] => 7046119
[patent_doc_number] => 20050250714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Crystalline forms of 9-(S)-erythromycylamine'
[patent_app_type] => utility
[patent_app_number] => 11/122537
[patent_app_country] => US
[patent_app_date] => 2005-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13900
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250714.pdf
[firstpage_image] =>[orig_patent_app_number] => 11122537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/122537 | Crystalline forms of 9-(S)-erythromycylamine | May 4, 2005 | Abandoned |
Array
(
[id] => 4682807
[patent_doc_number] => 20080249033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections'
[patent_app_type] => utility
[patent_app_number] => 11/568563
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22210
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249033.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568563 | Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections | May 2, 2005 | Abandoned |
Array
(
[id] => 4664153
[patent_doc_number] => 20080255060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Ester Linked Macrolides Useful For The Treatment of Microbial Infections'
[patent_app_type] => utility
[patent_app_number] => 11/568562
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40085
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255060.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568562 | Ester Linked Macrolides Useful For The Treatment of Microbial Infections | May 1, 2005 | Abandoned |
Array
(
[id] => 7187804
[patent_doc_number] => 20050192236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Crystaline clindamycin free base'
[patent_app_type] => utility
[patent_app_number] => 11/120264
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13415
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192236.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120264
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120264 | Crystaline clindamycin free base | May 1, 2005 | Abandoned |
Array
(
[id] => 7046118
[patent_doc_number] => 20050250713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => '11,12-Cyclic thiocarbamate macrolide antibacterial agents'
[patent_app_type] => utility
[patent_app_number] => 11/114502
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18987
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11114502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/114502 | 11,12-Cyclic thiocarbamate macrolide antibacterial agents | Apr 25, 2005 | Abandoned |
Array
(
[id] => 5721239
[patent_doc_number] => 20060074014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Dalbavancin compositions for treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 11/116064
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 64402
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074014.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116064 | Dalbavancin compositions for treatment of bacterial infections | Apr 25, 2005 | Abandoned |
Array
(
[id] => 876846
[patent_doc_number] => 07358346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'C-glycosides, uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/110864
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6648
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358346.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110864 | C-glycosides, uses thereof | Apr 20, 2005 | Issued |